文献速递心境障碍焦虑、强迫与应激相关障碍

在活体大脑中成像氯胺酮对突触密度(SV2A)的影响

Imaging the effect of ketamine on synaptic density (SV2A) in the living brain.
PubMed 文献 · Mol Psychiatry · 2022-02-15

研究使用正电子发射断层扫描(PET)和[11C]UCB-J(与突触囊泡蛋白2A即SV2A结合、反映轴突末梢密度的放射性配体)在非人灵长类、健康对照(HC)以及重性抑郁障碍(MDD)和/或创伤后应激障碍(PTSD)患者中,首次在人体探索氯胺酮是否通过恢复突触连接产生抗抑郁效应。总体未发现单次氯胺酮给药24小时后SV2A密度有可测量变化,尽管症状显著减轻。事后探索性分析提示基线SV2A密度较低的患者在给药24小时后SV2A密度可能增加,且该增加与抑郁严重度减轻及解离症状增加相关。

要点

  • 总体未发现单次氯胺酮给药24小时后SV2A密度有可测量变化,尽管症状显著减轻。
  • 事后探索性分析提示基线SV2A密度较低的患者给药24小时后SV2A密度可能增加。
  • 该SV2A增加与抑郁严重度减轻及解离症状增加相关,但需在更大样本中重复。

核心结论

  • 总体未发现单次氯胺酮给药24小时后SV2A密度有可测量变化,尽管症状显著减轻。
  • 事后探索性分析提示基线SV2A密度较低的患者给药24小时后SV2A密度可能增加。
  • 该SV2A增加与抑郁严重度减轻及解离症状增加相关,但需在更大样本中重复。
  • 需进一步工作以进一步确立氯胺酮疗效的突触前和突触后机制。

研究设计与样本

  • 使用正电子发射断层扫描(PET)和[11C]UCB-J(与SV2A结合、反映轴突末梢密度的放射性配体)在非人灵长类、健康对照(HC)以及重性抑郁障碍(MDD)和/或创伤后应激障碍(PTSD)患者中首次在人体研究氯胺酮对SV2A密度的影响。
  • 单次氯胺酮给药后24小时评估SV2A密度。

主要发现

  • 总体未发现非人灵长类、健康对照或MDD和/或PTSD患者单次氯胺酮给药24小时后SV2A密度有可测量变化,尽管症状显著减轻。
  • 事后探索性分析提示基线SV2A密度较低的患者给药24小时后SV2A密度可能增加。
  • 该SV2A增加与抑郁严重度减轻及解离症状增加相关。

局限性

  • 事后探索性分析结果需在更大样本中重复。
  • 需进一步工作以进一步确立氯胺酮疗效的突触前和突触后机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The discovery of ketamine as a rapid and robust antidepressant marks the beginning of a new era in the treatment of psychiatric disorders. Ketamine is thought to produce rapid and sustained antidepressant effects through restoration of lost synaptic connections. We investigated this hypothesis in humans for the first time using positron emission tomography (PET) and [11C]UCB-J-a radioligand that binds to the synaptic vesicle protein 2A (SV2A) and provides an index of axon terminal density. Overall, we did not find evidence of a measurable effect on SV2A density 24 h after a single administration of ketamine in non-human primates, healthy controls (HCs), or individuals with major depressive disorder (MDD) and/or posttraumatic stress disorder (PTSD), despite a robust reduction in symptoms. A post-hoc, exploratory analysis suggests that patients with lower SV2A density at baseline may exhibit increased SV2A density 24 h after ketamine. This increase in SV2A was associated with a reduction in depression severity, as well as an increase in dissociative symptoms. These initial findings suggest that a restoration of synaptic connections in patients with lower SV2A at baseline may underlie ketamine's therapeutic effects, however, this needs replication in a larger sample. Further work is needed to build on these initial findings and further establish the nuanced pre- and post-synaptic mechanisms underpinning ketamine's therapeutic effects.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Holmes SE, Finnema SJ, Naganawa M, et al. Imaging the effect of ketamine on synaptic density (SV2A) in the living brain. Mol Psychiatry. 2022. PMID: 35165397. doi:10.1038/s41380-022-01465-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。